BMS-351

• Target :

  Cytochromes P450|||Others

• Related Pathways :

  Others|||Metabolism

• Bioactivity :

  BMS-351 is a potent and selective, nonsteroidal CYP17A1 lyase inhibitor with robust selectivity over steroidogenic CYPs 21A2 and 11B1. BMS-351 emerges as an outstanding preclinical candidate to treat CRPC and is likely to minimize the side effects of current therapies due to its exceptional selectivity. BMS-351 is potentially useful for the Treatment of Prostate Cancer.

• Smiles :

  C(C(F)(F)F)N1C=2C(=C(C=CC2)C=3C(C)=CC=NC3)N=C1

• Molecular Formula :

  C15H12F3N3

• Molecular Weight :

  291.27

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1370001-71-0